Oncosynergy Is A Biotechnology Company Based In Greenwichconnecticutfounded In 2011 As A Spin Out From The University Of Californiasan Franciscothe Company Is Dedicated To Developing Innovative Therapeutics Aimed At Improving Outcomes For Patients With Unmet Needs In Oncologyparticularly Those Facing Aggressive Cancers Like Glioblastoma The Company Focuses On Creating A New Class Of Therapeutics Called Resistance Mechanism Inhibitorsrmis These Therapeutics Are Designed To Address Therapeutic Resistance In Cancer Treatment By Targeting Multiple Aspects Of Cancer Progressionone Of Their Key Products In Development Is Os2966A First In Class Anti Cd29 Monoclonal Antibody That Targets The Cd29 Receptorwhich Is Vital For Cancer Cell Survival Oncosynergy Has Secured A Total Investment Of $23 Million And Has Experienced Significant Growth In Its Workforcethe Company Is Currently Listed As Acquired
No conferences found for this company.
| Company Name | Oncosynergy Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
